Jasmine J Wang
Overview
Explore the profile of Jasmine J Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
290
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ju Y, Watson J, Wang J, Yen Y, Gevorkian L, Chen Z, et al.
Drug Resist Updat
. 2025 Feb;
79:101207.
PMID: 39914189
Background: B7-H3 is a promising target for cancer therapy, notably in prostate cancer (PCa), particularly in metastatic, castration-resistant PCa (mCRPC). With the development of B7-H3-targeted therapies, there is a need...
2.
Wang J, Sun N, Lee Y, Kim M, Vagner T, Rohena-Rivera K, et al.
Nano Today
. 2023 Jan;
48.
PMID: 36711067
Optimizing outcomes in prostate cancer (PCa) requires precision in characterization of disease status. This effort was directed at developing a PCa extracellular vesicle (EV) Digital Scoring Assay (DSA) for detecting...
3.
Sun N, Zhang C, Lee Y, Tran B, Wang J, Kim H, et al.
Hepatology
. 2022 Jul;
77(3):774-788.
PMID: 35908246
Background And Aims: The sensitivity of current surveillance methods for detecting early-stage hepatocellular carcinoma (HCC) is suboptimal. Extracellular vesicles (EVs) are promising circulating biomarkers for early cancer detection. In this...
4.
Sun N, Yang Y, Miao H, Redublo P, Liu H, Liu W, et al.
Biosens Bioelectron
. 2021 Dec;
199:113854.
PMID: 34896918
Circulating tumor cell (CTC) clusters are present in cancer patients with severe metastasis, resulting in poor clinical outcomes. However, CTC clusters have not been studied as extensively as single CTCs,...
5.
Lee Y, Sun N, Kim M, Wang J, Tran B, Zhang R, et al.
Liver Transpl
. 2021 Oct;
28(2):200-214.
PMID: 34664394
Numerous studies in hepatocellular carcinoma (HCC) have proposed tissue-based gene signatures for individualized prognostic assessments. Here, we develop a novel circulating tumor cell (CTC)-based transcriptomic profiling assay to translate tissue-based...
6.
Lee Y, Wang J, Zhu Y, Agopian V, Tseng H, Yang J
Clin Liver Dis (Hoboken)
. 2021 Aug;
17(6):409-413.
PMID: 34386205
No abstract available.
7.
Afshar Y, Dong J, Zhao P, Li L, Wang S, Zhang R, et al.
Nat Commun
. 2021 Aug;
12(1):4408.
PMID: 34344888
Placenta accreta spectrum (PAS) is a high-risk obstetrical condition associated with significant morbidity and mortality. Current clinical screening modalities for PAS are not always conclusive. Here, we report a nanostructure-embedded...
8.
Sun N, Lee Y, Kim M, Wang J, Zhang C, Teng P, et al.
Adv Mater Technol
. 2021 Jul;
6(5).
PMID: 34212072
Transcriptomic profiling of tumor tissues introduces a large database, which has led to improvements in the ability of cancer diagnosis, treatment, and prevention. However, performing tumor transcriptomic profiling in the...
9.
Lee Y, Tran B, Wang J, Liang I, You S, Zhu Y, et al.
Cancers (Basel)
. 2021 Jul;
13(12).
PMID: 34203086
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and one of the leading causes of cancer-related death worldwide. Despite the improvements in surveillance and treatment, the prognosis of...
10.
Lee Y, Wang J, Luu M, Noureddin M, Nissen N, Patel T, et al.
Hepatology
. 2021 Jun;
74(5):2622-2632.
PMID: 34114675
Background And Aims: Intrahepatic cholangiocarcinoma (iCCA) and hepatocellular carcinoma (HCC) are the most common primary liver cancers (PLCs). Differences in their clinical features and outcomes are open for investigation in...